secwatch.observer — SEC 8-K summary
======================================

Issuer:     InspireMD, Inc. (NSPR)
CIK:        0001433607
Form:       8-K
Filed at:   2024-11-25T23:59:59+00:00
Accession:  0001493152-24-047617
Event type: leadership
Sentiment:  positive
Materiality: 0.55
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InspireMD appoints medtech executive Scott R. Ward to Board of Directors
------------------------------------------------------------------------

- Scott R. Ward, former CEO of Cardiovascular Systems and Abbott leader, joins as Class II director.
- Ward received options for 16,647 shares and 43,548 restricted stock, vesting on one-year anniversary.
- Management highlights Ward's cardiovascular expertise ahead of potential U.S. approval of CGuard Prime.
- Ward has over 40 years healthcare experience, including 30 years at Medtronic in senior leadership roles.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1433607/000149315224047617/0001493152-24-047617-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1433607/000149315224047617/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-047617

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer